(Q28145191)
Statements
The long-term safety and efficacy of brinzolamide 1.0% (azopt) in patients with primary open-angle glaucoma or ocular hypertension. The Brinzolamide Long-Term Therapy Study Group (English)
0 references
February 2000
0 references
129
0 references
2
0 references
136-43
0 references